CYTOSORBENTS

CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.

#SimilarOrganizations #People #Financial #Event #Website #More

CYTOSORBENTS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

1997-01-01

Address:

Monmouth Junction, New Jersey, United States

Country:

United States

Website Url:

http://www.cytosorbents.com

Total Employee:

11+

Status:

Active

Contact:

7323298650

Email Addresses:

[email protected]

Total Funding:

22.56 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

Current Advisors List

not_available_image

Michael Bator Member Board of Directors @ Cytosorbents
Board_member
2015-06-01

Current Employees Featured

phillip-p-chan_image

Phillip P. Chan
Phillip P. Chan Chief Executive Officer and President @ Cytosorbents
Chief Executive Officer and President
2009-01-01

vincent-capponi_image

Vincent Capponi
Vincent Capponi President @ Cytosorbents
President
2020-05-01

vincent-capponi_image

Vincent Capponi
Vincent Capponi Chief Operating Officer @ Cytosorbents
Chief Operating Officer
2008-11-01

eric-mortensen_image

Eric Mortensen
Eric Mortensen Chief Medical Officer @ Cytosorbents
Chief Medical Officer
2017-05-01

kathleen-bloch_image

Kathleen Bloch
Kathleen Bloch Chief Financial Officer @ Cytosorbents
Chief Financial Officer
2013-05-01

daniel-wendt_image

Daniel Wendt
Daniel Wendt VP, Medical Affairs Cardiovascular @ Cytosorbents
VP, Medical Affairs Cardiovascular

efthymios-deliargyris_image

Efthymios Deliargyris
Efthymios Deliargyris Chief Medical Officer @ Cytosorbents
Chief Medical Officer
2020-05-01

not_available_image

Robert Bartlett
Robert Bartlett Chief Medical Officer @ Cytosorbents
Chief Medical Officer

Founder

frank-clark_image

Frank Clark

Stock Details

Company's stock symbol is NASDAQ:CTSO

Investors List

bridge-bank_image

Key Employee Changes

Date	New article
2021-12-21	CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular
2020-04-27	Cytosorbents appoints chief medical officer

Official Site Inspections

http://www.cytosorbents.com Semrush global rank: 4.29 M Semrush visits lastest month: 2.69 K

Host Informations
Whois Informations

Loading ...